Point72 Asset Management
DTIL icon

Point72 Asset Management’s Precision BioSciences DTIL Stock Holding History

Point72 Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$196K Buy
35,593
+5,986
+20% +$27.6K ﹤0.01% 3534
2025
Q4 		$123K Buy
+29,607
New +$168K ﹤0.01% 3716
2021
Q3 		– Sell
-3,847
Closed -$1.45M – 1084
2021
Q2 		$1.45M Buy
+3,847
New +$1.16M 0.01% 766
2020
Q4 		– Sell
-8,520
Closed -$1.57M – 957
2020
Q3 		$1.57M Buy
+8,520
New +$1.69M 0.01% 730

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Point72 Asset Management's DTIL Position: Q1 2026 in Review

Point72 Asset Management increased its Precision BioSciences (DTIL) stake by 20% in Q1 2026, buying an estimated $27.6K and bringing the position to 35,593 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #3534.

Point72 Asset Management first reported a position in DTIL in Q3 2020 and has held it in 4 quarters since. The position peaked at $1.57M in Q3 2020. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Point72 Asset Management held 35,593 shares of Precision BioSciences worth $196K as of Q1 2026.
  • Point72 Asset Management bought 5,986 Precision BioSciences shares in Q1 2026, an estimated $27.6K.
  • Precision BioSciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3534 holding.
  • Point72 Asset Management first reported a position in Precision BioSciences in Q3 2020 and has held it in 4 quarters since.
  • Point72 Asset Management's Precision BioSciences position peaked at $1.57M in Q3 2020.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.